Table 2 Associations between dietary components and transplant-related risk factors and GvHD.
Parameter | Carbohydrate | Protein | Fat | |||
|---|---|---|---|---|---|---|
Percent | P value | Percent | P value | Percent | P value | |
Treatment groups | ||||||
Chemotherapy-based conditioning | 45 (25–57) | 0.2 | 17 (11–29) | 0.02 | 34 (23–45) | 0.9 |
TBI-based conditioning | 46 (23–59) | 15 (11–25) | 33 (24–51) | |||
Acute GvHD | ||||||
No acute GvHD | 44 (25–57) | 0.3 | 18 (11–29) | 0.03 | 33 (23–45) | 0.7 |
Acute GvHD | 46 (23–59) | 16 (11–27) | 34 (24–44) | |||
Chronic GvHD | ||||||
No chronic GvHD | 45 (23–59) | 0.1 | 16 (11–29) | 0.2 | 34 (23–45) | 0.4 |
Chronic GvHD | 47 (28–57) | 15 (11–27) | 31 (24–51) | |||
Diagnosis | ||||||
Benign disease | 44 (30–57) | 0.06 | 18 (12–27) | 0.02 | 34 (23–45) | 0.6 |
Malignant disease | 47 (23–59) | 16 (11–29) | 33 (24–51) | |||
Donor match | ||||||
HLA-identical sibling | 46 (23–59) | 0.6 | 16 (11–27) | 0.8 | 34 (24–51) | 0.6 |
Other donors | 45 (25–57) | 16 (13–29) | 33 (23–37) | |||
